Research ArticleArticle
Open Access
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
Boulos Haraoui, Maria Bokarewa, Ian Kallmeyer and Vivian P. Bykerk
The Journal of Rheumatology October 2011, jrheum.110444; DOI: https://doi.org/10.3899/jrheum.110444
Boulos Haraoui
Maria Bokarewa
Ian Kallmeyer
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
Boulos Haraoui, Maria Bokarewa, Ian Kallmeyer, Vivian P. Bykerk
The Journal of Rheumatology Oct 2011, jrheum.110444; DOI: 10.3899/jrheum.110444
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
Boulos Haraoui, Maria Bokarewa, Ian Kallmeyer, Vivian P. Bykerk
The Journal of Rheumatology Oct 2011, jrheum.110444; DOI: 10.3899/jrheum.110444